Patents by Inventor Yanrong Lu

Yanrong Lu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MIKTOARM STAR POLYMER AS CEMENT FLUID ADDITIVES
    Publication number: 20250011514
    Abstract: Provided is Miktoarm star polymers, which are provided either as an aqueous solution or as thin micro-flakes. Also provided is a process of making the star polymers thereof. These polymers bear short polyacrylic segment(s) and long buoyant sulfonated polymer segment(s), which were found to be effective as additives for cement slurry water retention and as a plasticizer.
    Type: Application
    Filed: July 3, 2024
    Publication date: January 9, 2025
    Applicant: SOLENIS TECHNOLOGIES, L.P.
    Inventors: Leo Zhaoqing Liu, Yanrong Lu
  • Establishment of rhesus monkey model of autoimmunity type 1 diabetes
    Patent number: 9186421
    Abstract: Use of low dose streptozocin in the preparation of an animal model for screening drugs for treatment of antoimmune type 1 diabetes is disclosed, in which streptozocin is administrated intravenously at a dose of 15-30 mg/kg per time for 5 days and administrated again on the 7th day and 14th day after last time of offering drug. A method for preparing rhesus monkey model of autoimmune type 1 diabetes and autoimmune type 1 diabetes animal model obtained are also disclosed.
    Type: Grant
    Filed: March 26, 2010
    Date of Patent: November 17, 2015
    Assignee: West China Hospital, Sichuan University
    Inventors: Yanrong Lu, Jingqiu Cheng, Shaoping Deng, Younan Chen, Bole Tian, Gang Mai, Yan Ren, Li Wang, Hongxia Li, Lingling Wei, Xi Jin, Chaofeng Qiao, Wensheng Zhang, Sirong He, Li Zeng
  • ESTABLISHMENT OF RHESUS MONKEY MODEL OF AUTOIMMUNITY TYPE 1 DIABETES
    Publication number: 20130149733
    Abstract: Use of low dose streptozocin in the preparation of an animal model for screening drugs for treatment of antoimmune type 1 diabetes is disclosed, in which streptozocin is administrated intravenously at a dose of 15-30 mg/kg per time for 5 days and administrated again on the 7th day and 14th day after last time of offering drug. A method for preparing rhesus monkey model of autoimmune type 1 diabetes and autoimmune type 1 diabetes animal model obtained are also disclosed.
    Type: Application
    Filed: March 26, 2010
    Publication date: June 13, 2013
    Applicant: West China Hospital, Sichuan University
    Inventors: Yanrong Lu, Jingqiu Cheng, Shaoping Deng, Younan Chen, Bole Tian, Gang Mai, Yan Ren, Li Wang, Hongxia Li, Lingling Wei, Xi Jin, Chaofeng Qiao, Wensheng Zhang, Sirong He, Li Zeng